{"id":5643,"date":"2023-05-03T17:36:44","date_gmt":"2023-05-03T22:36:44","guid":{"rendered":"https:\/\/www.nhg.mx\/?p=5643"},"modified":"2023-05-03T17:57:24","modified_gmt":"2023-05-03T22:57:24","slug":"cofece-commences-an-investigation-of-a-possible-cartel-in-the-market-for-commercialization-and-distribution-of-scopolamine-in-mexico","status":"publish","type":"post","link":"https:\/\/www.nhg.mx\/es\/cofece-commences-an-investigation-of-a-possible-cartel-in-the-market-for-commercialization-and-distribution-of-scopolamine-in-mexico\/","title":{"rendered":"COFECE commences an investigation of a possible cartel in the market for commercialization and distribution of scopolamine in Mexico"},"content":{"rendered":"<p>By means of a notice published in the Federal Official Gazette on May 2, 2023, the Federal Economic Competition Commission (Commission) announced the commencement of an investigation regarding a possible cartel in the market for the commercialization and distribution of scopolamine (Hyoscine, Butylscopolamine bromide, Scopolamine butylbromide, Hyoscine butylbromide, N-Butylbromide Scopolamine, Hyoscine butylbromide and related) in the national territory.<\/p>\n<p>It is worth noting that health was identified as a priority sector in the Commission&#8217;s Strategic Plan for 2022-2025. This investigation adds to various efforts that the Commission has made between 2016 and 2021 to identify unlawful practices in the pharmaceutical industry, particularly in the markets for the production, distribution, and marketing of medicines, public bids of laboratory and blood bank studies, as well as toothbrushes, condoms, and latex probes.<\/p>\n<p>The investigation began on October 26, 2022, and may take 120 business days (with four possible extensions of 120 days, each).<\/p>\n<p>Fines for such practices may equal up to 10% of the revenues of companies that are identified as responsible for this practice, in addition to administrative and criminal penalties that may apply to the involved individuals.<\/p>\n<p>If you require information or advice regarding this investigation, please contact our competition &amp; antitrust practice group:<\/p>\n<p><strong>Alejandro Mendiola, partner at NHG<\/strong><br \/>\n<a href=\"mailto:amendiola@nhg.com.mx\">amendiola@nhg.com.mx<\/a><br \/>\n+52 55 4170 3024<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><strong>Alerta de Competencia Econ\u00f3mica \u2013 COFECE inicia investigaci\u00f3n por posibles pr\u00e1cticas monop\u00f3licas absolutas en el mercado de distribuci\u00f3n y comercializaci\u00f3n de escopolamina en M\u00e9xico<\/strong><\/p>\n<p>A trav\u00e9s de un aviso publicado en el Diario Oficial de la Federaci\u00f3n el 2 de mayo de 2023, la Comisi\u00f3n Federal de Competencia Econ\u00f3mica (Comisi\u00f3n) inform\u00f3 el inicio de una investigaci\u00f3n por la posible comisi\u00f3n de pr\u00e1cticas monop\u00f3licas absolutas en el mercado de comercializaci\u00f3n y distribuci\u00f3n de escopolamina (Hioscina, Butilescopolamina bromide, Escopolamina butilbromide, Hioscina butilbromide, N-Butilbromide Escopolamina, butilbromuro de hioscina y relacionados) en el territorio nacional.<\/p>\n<p>Cabe destacar que el sector salud fue identificado como prioritario en el Plan Estrat\u00e9gico de la Comisi\u00f3n para los a\u00f1os 2022-2025. Esta investigaci\u00f3n se suma a diversos esfuerzos que ha hecho la Comisi\u00f3n entre 2016 y 2021 para identificar pr\u00e1cticas anticompetitivas en la industria farmac\u00e9utica, particularmente en los mercados de producci\u00f3n, distribuci\u00f3n y comercializaci\u00f3n de medicamentos; contrataci\u00f3n p\u00fablica de estudios de laboratorio y banco de sangre, as\u00ed como cepillos dentales, condones y sondas de l\u00e1tex.<\/p>\n<p>La investigaci\u00f3n inici\u00f3 el 26 de octubre de 2022, y podr\u00e1 durar 120 d\u00edas h\u00e1biles (con cuatro posibles extensiones de 120 d\u00edas, cada una).<\/p>\n<p>Las multas por este tipo de pr\u00e1cticas pueden ser de hasta el 10% de los ingresos de las empresas que sean identificadas como responsables de cometer esta pr\u00e1ctica, adem\u00e1s de las sanciones administrativas y penales que pueden resultar aplicables para los individuos involucrados.<\/p>\n<p>Si requiere informaci\u00f3n o asesor\u00eda en relaci\u00f3n con esta investigaci\u00f3n, contacte a nuestro equipo de competencia econ\u00f3mica.<\/p>\n<p><strong>Alejandro Mendiola, socio de NHG<\/strong><br \/>\n<a href=\"mailto:amendiola@nhg.com.mx\">amendiola@nhg.com.mx<\/a><br \/>\n+52 55 4170 3024<\/p>\n<div class=\"pdfprnt-buttons pdfprnt-buttons-post pdfprnt-bottom-left\"><a href=\"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/posts\/5643?print=pdf\" class=\"pdfprnt-button pdfprnt-button-pdf\" target=\"_blank\"><img decoding=\"async\" src=\"https:\/\/www.nhg.mx\/wp-content\/plugins\/pdf-print\/images\/pdf.png\" alt=\"image_pdf\" title=\"View PDF\" \/><\/a><a href=\"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/posts\/5643?print=print\" class=\"pdfprnt-button pdfprnt-button-print\" target=\"_blank\"><img decoding=\"async\" src=\"https:\/\/www.nhg.mx\/wp-content\/plugins\/pdf-print\/images\/print.png\" alt=\"image_print\" title=\"Print Content\" \/><\/a><\/div>","protected":false},"excerpt":{"rendered":"<p>By means of a notice published in the Federal Official Gazette on May 2, 2023, the Federal Economic Competition Commission (Commission) announced the commencement of an investigation regarding a possible cartel in the market for the commercialization and distribution of scopolamine (Hyoscine, Butylscopolamine bromide, Scopolamine butylbromide, Hyoscine butylbromide, N-Butylbromide Scopolamine, Hyoscine butylbromide and related) in&#8230;<\/p>\n<div class=\" [&hellip;]\"><a href=\"https:\/\/www.nhg.mx\/es\/cofece-commences-an-investigation-of-a-possible-cartel-in-the-market-for-commercialization-and-distribution-of-scopolamine-in-mexico\/\">Read More<\/a><\/div>\n","protected":false},"author":9,"featured_media":5645,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[115,386],"tags":[325,490,563,562],"class_list":["post-5643","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-antitrust","category-legal-alerts","tag-antitrust","tag-competencia-economica","tag-escopolamina","tag-scopolamine"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/posts\/5643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/comments?post=5643"}],"version-history":[{"count":0,"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/posts\/5643\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/media\/5645"}],"wp:attachment":[{"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/media?parent=5643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/categories?post=5643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nhg.mx\/es\/wp-json\/wp\/v2\/tags?post=5643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}